La catena delle opzioni mostra i dati chiave delle opzioni azionarie di CAE a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per CAE..

CAE (NYSE:CAE) Azioni, Catena delle Opzioni

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Goldman Sachs analyst Anthony Valentini assumes CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) with a Buy rating and announces Price Target of $33.

News

Price Target

Initiation

Analyst Ratings

Goldman Sachs Assumes CAE at Buy, Announces Price Target of $33

CAE Receives Regulatory Approval To Renew Normal Course Issuer Bid To Purchase, For Cancellation, Up To 16.0M Shares Commencing June 10, 2025 And Ending June 9, 2026

(NYSE:&nbsp;CAE) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CAE#TSX">CAE</a>)&nbsp;CAE Inc. today announced the appointment of Matthew Bromberg as President and Chief Executive Officer (CEO), effective August 13, 2025. In this role, Mr. Bromberg will lead the company's strategic growth and drive its continued evolution into the future. Mr. Bromberg will also be a nominee for election to the Board at the upcoming Annual and Special Meeting of Shareholders.
CAE also announced that Calin Rovinescu will become Executive Chairman of the Board and that Sophie Brochu will serve as Lead Independent Director, reflecting CAE's commitment to strong, best-in-class governance.
The appointment of Mr. Bromberg has been approved by CAE's Board of Directors and will take effect as part of an orderly transition plan after the 2025 Annual and Special Meeting of Shareholders. This coincides with the previously announced departure of Marc Parent as CAE's President and CEO. Mr. Bromberg will join CAE effective June 16, 2025, as Incoming President and CEO, working closely with Mr. Parent throughout the transition.

Management

TSX:CAE

CAE Taps Matthew Bromberg as New CEO, Replacing Longtime Leader Marc Parent

RBC Capital analyst James McGarragle downgrades CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) from Outperform to Sector Perform and lowers the price target from $41 to $38.

Downgrades

RBC Capital Downgrades CAE to Sector Perform, Lowers Price Target to $38

Jefferies analyst Sheila Kahyaoglu maintains CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) with a Hold and lowers the price target from $28 to $27.

Jefferies Maintains Hold on CAE, Lowers Price Target to $27

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Alejandro Demichelis upgraded Petróleo Brasileiro S.A. &#8211; Petrobras (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) from Hold to Buy and announced a $15.3 price target. Petrobras Brasileiro shares closed at $12.15 on Wednesday. <a href="https://www.benzinga.com/quote/pbr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Mitchell Kapoor upgraded the rating for CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) from Neutral to Buy and maintained the price target of $5. CytomX Therapeutics shares closed at $2.38 on Wednesday. <a href="https://www.benzinga.com/quote/ctmx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Konark Gupta upgraded the rating for CAE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CAE#TSX">CAE</a>) from Sector Perform to Sector Outperform and announced a C$42 price target. <a href="https://www.benzinga.com/quote/cae/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Aaron Rakers upgraded Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) from Equal-Weight to Overweight and raises the price target from $72 to $75. Cisco shares closed at $61.29 on Wednesday. <a href="https://www.benzinga.com/quote/csco/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying CTMX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="599" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15081526/image-180-1024x599.png" alt="" class="wp-image-916400" style="width:650px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15081526/image-180-1024x599.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15081526/image-180-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15081526/image-180-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15081526/image-180.png 1133w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock">Jim Cramer: SoFi Goes To &#8216;New Highs,&#8217; Recommends Not Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

CSCO

CTMX

This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

WIIM

CAE shares are trading lower after the company reported mixed Q4 financial results.

CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.32 by 3.13 percent. This is a 22.22 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $888.47 million which missed the analyst consensus estimate of $909.25 million by 2.29 percent. This is a 6.32 percent increase over sales of $835.64 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

CORRECTION: CAE Q4 Adj. EPS $0.33 Beats $0.32 Estimate, Sales $888.47M Miss $909.25M Estimate

ABOS

ABSI

ACCS

ACHV

ACXP

ADAP

ALCO

ALLO

ASNS

AUID

AVXL

BDSX

BEAT

BKTI

BWAY

BWEN

CAMT

CAPR

CINT

CLPT

CLRB

CNCK

CYBR

DARE

DLPN

DMAC

ELMD

ETON

EXEL

FENC

FLOC

FTHM

GAIN

GAUZ

GENK

GEVO

GNSS

GOCO

GRAL

GUTS

HSON

HUMA

HUYA

HYFM

HYLN

HYPR

ICMB

IMOS

INLX

IRIX

ITRM

IZEA

KOPN

KRMN

LCTX

LEGN

LOAR

LSTR

LUNR

LXRX

MASS

MBRX

MCHX

MDAI

MGNX

MPTI

NMTC

NPCE

NUTX

NUWE

NXGL

NYAX

OKLO

ONON

OPXS

PERI

PRTS

PSFE

PXLW

Earnings Scheduled For May 13, 2025

CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that CAE will report an earnings per share (EPS) of $0.47.
Investors in CAE are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.01, leading to a 13.91% increase in the share price on the subsequent day.
Here's a look at CAE's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.13</td>
<td>0.16</td>
<td>0.31</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.21</td>
<td>0.18</td>
<td>0.15</td>
<td>0.27</td>
</tr>
<tr>
<td>Price Change %</td>
<td>14.000000000000002%</td>
<td>11.0%</td>
<td>5.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747058517_0.png" alt="eps graph" />
<h3>Market Performance of CAE's Stock</h3>
Shares of CAE were trading at $25.94 as of May 09. Over the last 52-week period, shares are up 23.18%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CAE/earnings">To track all earnings releases for CAE visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For CAE

General

CAE Rebrands Portfolio Of Airline Operations Solutions To Flightscape – Powered By CAE

ATRO

AVAV

AXON

BWXT

BYRN

CDRE

Embraer-Empresa Brasileira De Aeronautica

ESLT

EVEX

EVTL

MRCY

SARO

SATL

SPAI

SPCE

Shares of aerospace and defense companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

RBC Capital analyst James McGarragle reiterates CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) with a Outperform and maintains $43 price target.

Reiteration

RBC Capital Reiterates Outperform on CAE, Maintains $43 Price Target

Goldman Sachs analyst Noah Poponak maintains CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) with a Buy and raises the price target from $28 to $32.

Goldman Sachs Maintains Buy on CAE, Raises Price Target to $32

RBC Capital analyst James McGarragle maintains CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) with a Outperform and raises the price target from $38 to $43.

RBC Capital Maintains Outperform on CAE, Raises Price Target to $43

U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday.
Shares of The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/GT/analyst-ratings">quarterly financial results</a>.
Goodyear Tire &amp; Rubber reported quarterly earnings of 39 cents per share which beat the analyst consensus estimate of 31 cents per share. The company reported quarterly sales of $4.95 billion which beat the analyst consensus estimate of $4.87 billion.
Goodyear Tire &amp; Rubber shares jumped 19.4% to $9.76 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares jumped 97.7% to $33.94 after Nvidia disclosed a stake of 1.74 million shares in a 13F filing.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 34.6% to $8.65 following upbeat quarterly earnings.</li>
<li>Udemy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>) gained 23.7% to $9.67 after the company reported fourth-quarter earnings and revenue above estimates.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 20.9% to $1.7900 following upbeat quarterly earnings.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 20.3% to $20.86.</li>
<li>Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) gained 17.2% to $5.85.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) gained 17% to $38.90 following fourth-quarter results.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) climbed 16% to $17.25.</li>
<li>Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) gained 15.8% to $163.43 following a quarterly revenue beat. Multiple analysts upgraded the stock following the report.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 15.2% to $100.00 following better-than-expected quarterly financial results.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) gained 14.8% to $32.85.</li>
<li>CAE Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) rose 14.7% to $26.98 after the company reported a year-over-year increase in third-quarter financial results.</li>
<li>DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) gained 13.3% to $52.62 after the company reported better-than-expected quarterly adjusted EPS results and raised its FY25 revenue guidance.</li>
<li>West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) rose 11.2% to $221.56.</li>
<li>Pilgrim&#8217;s Pride Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPC#NASDAQ">PPC</a>) gained 9.6% to $57.07.</li>
<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) rose 5.3% to $13.43</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Intraday Update

Movers

ABNB

BEAM

DKNG

PACB

PONY

PSNL

ROKU

UDMY

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday

CAE shares are trading higher after the company reported a year-over-year increase in Q3 financial results.

CAE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) reported quarterly earnings of $0.21 per share. This is a 16.67 percent increase over earnings of $0.18 per share from the same period last year. The company reported $874.000 million in sales this quarter. This is a 8.68 percent increase over sales of $804.176 million the same period last year.

CAE Q3 2025 Adj. EPS US $0.21 Up From $0.18 YoY, Sales US $874.000M Up From $804.176M YoY

Comments

CAE

CAE (CAE) Opzioni

CAE (NYSE:CAE) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO